Literature DB >> 1641287

Passive smoking and middle ear effusion among children in day care.

R A Etzel1, E N Pattishall, N J Haley, R H Fletcher, F W Henderson.   

Abstract

One hundred thirty-two children who attended a research day-care center were studied to determine whether passive tobacco smoke exposure was associated with an increased rate of otitis media with effusion or with an increased number of days with otitis media with effusion during the first 3 years of life. Based on preliminary studies, a serum cotinine concentration of greater than or equal to 2.5 ng/mL was considered indicative of exposure to tobacco smoke. Otitis media with effusion was diagnosed using pneumatic otoscopy by nurse practitioners and pediatricians who reviewed the children's health status each weekday. The 87 children with serum cotinine concentrations greater than or equal to 2.5 ng/mL had a 38% higher rate of new episodes of otitis media with effusion during the first 3 years of life than the 45 children with lower or undetectable serum cotinine concentrations (incidence density ratio = 1.38, 95% confidence interval 1.21 to 1.56). The average duration of an episode of otitis media with effusion was 28 days in the children with elevated cotinine concentrations and 19 days in the children with lower cotinine concentrations (P less than .01). It is estimated that 8% of the cases of otitis media with effusion in this population and 17.6% of the days with otitis media with effusion may be attributable to exposure to tobacco smoke.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641287

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

1.  Do we need to treat otitis media?

Authors:  S Chaudhary
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Assessment of interindividual and geographic variability in human exposure to fine particulate matter in environmental tobacco smoke.

Authors:  Ye Cao; H Christopher Frey
Journal:  Risk Anal       Date:  2010-10-29       Impact factor: 4.000

3.  Fetal exposure to secondhand tobacco smoke assessed by maternal self-reports and cord blood cotinine: prospective cohort study in Krakow.

Authors:  Wieslaw Jedrychowski; Frederica Perera; Elzbieta Mroz; Susan Edwards; Elzbieta Flak; John T Bernert; Dorota Mrozek-Budzyn; Agata Sowa; Agnieszka Musiał
Journal:  Matern Child Health J       Date:  2008-04-25

4.  Serum cotinine levels should optimally be measured when evaluating the outcomes of cartilage tympanoplasty in smokers.

Authors:  Xudan Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-04       Impact factor: 2.503

5.  A longitudinal study of risk factors for otitis media in African American children.

Authors:  Susan A Zeisel; Joanne E Roberts; Margaret Burchinal; Eloise Neebe; Frederick W Henderson
Journal:  Matern Child Health J       Date:  2002-09

6.  Predictors of smoking cessation counseling adherence in a socioeconomically disadvantaged sample of pregnant women.

Authors:  Kuang-Yi Wen; Suzanne M Miller; Amy Lazev; Zhu Fang; Enrique Hernandez
Journal:  J Health Care Poor Underserved       Date:  2012-08

Review 7.  What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media?

Authors:  Young J Juhn; Chung-Il Wi
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

8.  Selecting persistent glue ear for referral in general practice: a risk factor approach.

Authors: 
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

9.  Cartilage tympanoplasty: a reliable technique for smokers.

Authors:  E Kyrodimos; G A Stamatiou; E Margaritis; D Kikidis; A Sismanis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-26       Impact factor: 2.503

10.  Prenatal and postnatal parental smoking and acute otitis media in early childhood.

Authors:  S E Håberg; Y E Bentdal; S J London; K J Kvaerner; W Nystad; P Nafstad
Journal:  Acta Paediatr       Date:  2010-01       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.